SELLAS Life Sciences (SLS) Accounts Payables (2019 - 2024)
Historic Accounts Payables for SELLAS Life Sciences (SLS) over the last 9 years, with Q3 2024 value amounting to $4.5 million.
- SELLAS Life Sciences' Accounts Payables rose 476.96% to $4.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $4.5 million, marking a year-over-year increase of 476.96%. This contributed to the annual value of $5.6 million for FY2023, which is 6797.74% up from last year.
- Per SELLAS Life Sciences' latest filing, its Accounts Payables stood at $4.5 million for Q3 2024, which was up 476.96% from $6.3 million recorded in Q2 2024.
- Over the past 5 years, SELLAS Life Sciences' Accounts Payables peaked at $7.4 million during Q1 2024, and registered a low of $1.8 million during Q3 2020.
- Moreover, its 5-year median value for Accounts Payables was $3.1 million (2023), whereas its average is $3.6 million.
- Per our database at Business Quant, SELLAS Life Sciences' Accounts Payables crashed by 5396.18% in 2021 and then soared by 13901.26% in 2024.
- SELLAS Life Sciences' Accounts Payables (Quarter) stood at $4.7 million in 2020, then tumbled by 53.96% to $2.1 million in 2021, then soared by 56.58% to $3.4 million in 2022, then surged by 67.98% to $5.6 million in 2023, then fell by 19.37% to $4.5 million in 2024.
- Its last three reported values are $4.5 million in Q3 2024, $6.3 million for Q2 2024, and $7.4 million during Q1 2024.